Siemens Healthineers AG Unsponsored ADR (SMMNY)
OTHER OTC:SMMNY
SMMNY Stock Chart & Stats
$26.02
--
Market closed
$26.02
--
Day’s Range― - ―
52-Week Range$20.60 - $28.79
Previous CloseN/A
VolumeN/A
Average Volume (3M)1.52K
Market Cap
$46.22B
Enterprise Value$53.21B
Total Cash (Recent Filing)$2.14B
Total Debt (Recent Filing)$15.16B
Price to Earnings (P/E)28.0
Beta1.07
Next Earnings
May 12, 2026EPS Estimate
0.3Next Dividend Ex-DateN/A
Dividend Yield1.98%
Share Statistics
EPS (TTM)0.29
Shares Outstanding2,256,000,000
10 Day Avg. Volume0
30 Day Avg. Volume1,521
Financial Highlights & Ratios
PEG Ratio7.41
Price to Book (P/B)2.44
Price to Sales (P/S)2.34
P/FCF Ratio24.19
Enterprise Value/Market Cap1.15
Enterprise Value/Revenue2.43
Enterprise Value/Gross Profit5.67
Enterprise Value/Ebitda11.72
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1.35
Revenue Forecast (FY)$27.99B
Bulls Say, Bears Say
Bulls Say
Recurring Revenue From Installed BaseThe business model emphasizes recurring revenue from services, consumables and software tied to a large installed base and long equipment replacement cycles. This creates durable revenue visibility, higher lifetime customer value and resilience versus single-sale cycles over the next 2–6 months.
Stable Profitability And ROEConsistent mid‑teens operating margins and double‑digit ROE indicate sustainable profitability from core medical devices and services. Strong margin profile supports cash generation and reinvestment capability, underpinning long‑term competitiveness despite cyclical demand shifts.
Imaging & Precision Therapy MomentumHigh single‑digit growth, positive book‑to‑bill and noted AI/next‑gen product launches indicate durable structural strength in the synergetic core. Market share gains and differentiated tech (photon counting CT, interventional MRI) support sustained revenue and margin expansion over coming quarters.
Bears Say
Diagnostics China DisruptionStructural changes in China (volume‑based procurement and reimbursement cuts) are reducing prices, volumes and profit conversion for Diagnostics. Given China’s size, this creates a multi‑quarter headwind to diagnostic sales and margins until pricing/reimbursement dynamics normalize or portfolio mix shifts.
Tariff And FX HeadwindsMaterial tariff and currency impacts are compressing reported margins and EPS, and management expects continued drag into the full year. These macro headwinds hinder sustainable margin improvement and require operational offsets, raising execution risk for maintaining profit expansion.
Leverage And Cash Flow VolatilityMeaningful absolute debt and moderately elevated leverage limit financial flexibility if growth falters. Coupled with volatile free cash flow and weaker FCF growth, balance sheet capacity to fund acquisitions, buybacks or heavy capex is constrained, increasing vulnerability to prolonged demand softness.
Siemens Healthineers AG Unsponsored ADR News
SMMNY FAQ
What was Siemens Healthineers AG Unsponsored ADR’s price range in the past 12 months?
Siemens Healthineers AG Unsponsored ADR lowest stock price was $20.60 and its highest was $28.79 in the past 12 months.
What is Siemens Healthineers AG Unsponsored ADR’s market cap?
Siemens Healthineers AG Unsponsored ADR’s market cap is $46.22B.
When is Siemens Healthineers AG Unsponsored ADR’s upcoming earnings report date?
Siemens Healthineers AG Unsponsored ADR’s upcoming earnings report date is May 12, 2026 which is in 36 days.
How were Siemens Healthineers AG Unsponsored ADR’s earnings last quarter?
Siemens Healthineers AG Unsponsored ADR released its earnings results on Jan 29, 2026. The company reported $0.289 earnings per share for the quarter, beating the consensus estimate of $0.263 by $0.026.
Is Siemens Healthineers AG Unsponsored ADR overvalued?
According to Wall Street analysts Siemens Healthineers AG Unsponsored ADR’s price is currently Overvalued.
Does Siemens Healthineers AG Unsponsored ADR pay dividends?
Siemens Healthineers AG Unsponsored ADR pays a Annually dividend of $0.521 which represents an annual dividend yield of 1.98%. See more information on Siemens Healthineers AG Unsponsored ADR dividends here
What is Siemens Healthineers AG Unsponsored ADR’s EPS estimate?
Siemens Healthineers AG Unsponsored ADR’s EPS estimate is 0.3.
How many shares outstanding does Siemens Healthineers AG Unsponsored ADR have?
Siemens Healthineers AG Unsponsored ADR has 2,256,000,000 shares outstanding.
What happened to Siemens Healthineers AG Unsponsored ADR’s price movement after its last earnings report?
Siemens Healthineers AG Unsponsored ADR reported an EPS of $0.289 in its last earnings report, beating expectations of $0.263. Following the earnings report the stock price went down -1.108%.
Which hedge fund is a major shareholder of Siemens Healthineers AG Unsponsored ADR?
Currently, no hedge funds are holding shares in SMMNY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Siemens Healthineers AG Unsponsored ADR Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-6.89%
12-Months-Change
Fundamentals
Return on Equity
11.65%
Trailing 12-Months
Asset Growth
3.91%
Trailing 12-Months
Company Description
Siemens Healthineers AG Unsponsored ADR
Siemens Healthineers AG Unsponsored ADR (SMMNY) is a global leader in medical technology and healthcare solutions, providing innovative and high-quality products and services in the fields of imaging, diagnostics, and digital health. The company operates primarily in the healthcare sector, focusing on areas such as imaging systems (including MRI, CT, and ultrasound), laboratory diagnostics, and advanced therapies. Siemens Healthineers aims to enhance patient care by delivering cutting-edge technologies and solutions that improve clinical outcomes and operational efficiency in healthcare settings.
Technical Analysis
Ownership Overview
―
Insiders
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---